{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:03:15Z","timestamp":1781114595711,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","award":["81473334"],"award-info":[{"award-number":["81473334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","award":["81274047"],"award-info":[{"award-number":["81274047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","award":["81503201"],"award-info":[{"award-number":["81503201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","award":["81303146"],"award-info":[{"award-number":["81303146"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Distinguished Professor of Liaoning Province, Dalian Outstanding Youth Science and Technology Talent","award":["2014J11JH132"],"award-info":[{"award-number":["2014J11JH132"]}]},{"name":"Distinguished Professor of Liaoning Province, Dalian Outstanding Youth Science and Technology Talent","award":["2015J12JH201"],"award-info":[{"award-number":["2015J12JH201"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.phrs.2016.05.013","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T20:31:22Z","timestamp":1463603482000},"page":"139-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction"],"prefix":"10.1016","volume":"110","author":[{"given":"Min","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangge","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokui","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.05.013_bib0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jchromb.2015.01.036","article-title":"Determination and pharmacokinetic study of two triterpenoid saponins in rat plasma after oral administration of the extract of aralia elata leaves by UHPLC-ESI-MS\/MS","volume":"985","author":"Wang","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.phrs.2016.05.013_bib0010","doi-asserted-by":"crossref","first-page":"167253","DOI":"10.1155\/2014\/167253","article-title":"Pharmacokinetic comparative study of gastrodin and rhynchophylline after oral administration of different prescriptions of yizhi tablets in rats by an HPLC-ESI\/MS method","volume":"2014","author":"Ge","year":"2014","journal-title":"Evid Based Complement. Altern. Med."},{"key":"10.1016\/j.phrs.2016.05.013_bib0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.steroids.2014.08.023","article-title":"Simultaneous quantification of five steroid saponins from Dioscorea zingiberensis C.H. Wright in rat plasma by HPLC-MS\/MS and its application to the pharmacokinetic studies","volume":"93","author":"Zhang","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.phrs.2016.05.013_bib0020","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s11606-008-0632-y","article-title":"Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center","volume":"23","author":"Bent","year":"2008","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.phrs.2016.05.013_bib0025","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ctrv.2012.12.008","article-title":"Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients","volume":"39","author":"Goey","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phrs.2016.05.013_bib0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1517\/17425255.2014.873786","article-title":"Drug interactions with phytotherapeutics in oncology","volume":"10","author":"Haefeli","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0035","doi-asserted-by":"crossref","first-page":"594354","DOI":"10.1155\/2014\/594354","article-title":"The inhibition of the components from shengmai injection towards UDP-glucuronosyltransferase","volume":"2014","author":"Jiang","year":"2014","journal-title":"Evid Based Complement. Altern. Med."},{"key":"10.1016\/j.phrs.2016.05.013_bib0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2014.02.021","article-title":"Herb-drug interaction prediction based on the high specific inhibition of andrographolide derivatives towards UDP-glucuronosyltransferase (UGT) 2B7","volume":"277","author":"Ma","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0045","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1517\/17425255.2010.510132","article-title":"Effects of herbal products on the metabolism and transport of anticancer agents","volume":"6","author":"He","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0050","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.2174\/092986711797535317","article-title":"Clinical herbal interactions with conventional drugs: from molecules to maladies","volume":"18","author":"Chen","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2016.05.013_bib0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.fct.2014.03.004","article-title":"Evaluation of the in vitro\/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition\/induction and UDP-glucuronosyltransferase inhibition","volume":"68","author":"Zheng","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jep.2015.01.010","article-title":"Herb-drug interaction between an anti-HIV Chinese herbal SH formula and atazanavir in vitro and in vivo","volume":"162","author":"Cheng","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0065","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jep.2013.09.055","article-title":"Liquorice, a unique guide drug of traditional Chinese medicine: a review of its role in drug interactions","volume":"150","author":"Wang","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40262-013-0102-5","article-title":"The effect of St John's wort on the pharmacokinetics of docetaxel","volume":"53","author":"Goey","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.phrs.2016.05.013_bib0075","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1038\/srep04362","article-title":"Soybean greatly reduces valproic acid plasma concentrations: a food-drug interaction study","volume":"4","author":"Marahatta","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2016.05.013_bib0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1389200003339171","article-title":"UDP-glucuronosyltransferases","volume":"1","author":"King","year":"2000","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.phrs.2016.05.013_bib0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-2797(00)00198-8","article-title":"Roles of glucuronidation and UDP-glucuronosyltransferase in xenobiotic bioactivation reactions","volume":"129","author":"Ritter","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phrs.2016.05.013_bib0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1389200053586127","article-title":"A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years","volume":"6","author":"Radominska-Pandya","year":"2005","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.phrs.2016.05.013_bib0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/03602530903208561","article-title":"Renal UDP-glucuronosyltransferase and the glucuronidation of xenobiotics and endogenous mediators","volume":"42","author":"Knights","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.phrs.2016.05.013_bib0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2013.09.002","article-title":"Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: a quantitative systematic review","volume":"141","author":"Stingl","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.05.013_bib0105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pharmthera.2012.01.009","article-title":"The glycosidation of xenobiotics and endogenous compounds: versatility and redundancy in the UDP glycosyltransferase superfamily","volume":"134","author":"Meech","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.05.013_bib0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pharmthera.2004.10.013","article-title":"UDP-glucuronosyltransferases and clinical drug\u2013drug interactions","volume":"106","author":"Kiang","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.05.013_bib0115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3109\/00498254.2011.563327","article-title":"N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferase","volume":"41","author":"Kaivosaari","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.phrs.2016.05.013_bib0120","first-page":"507","article-title":"Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3","volume":"26","author":"Green","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phrs.2016.05.013_bib0125","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1124\/dmd.113.051565","article-title":"Human UDP-glucuronosyltransferase (UGT) 2B10 in drug n-glucuronidation: substrate screening and comparison with UGT1A3 and UGT1A4","volume":"41","author":"Kato","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phrs.2016.05.013_bib0130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.toxlet.2014.11.018","article-title":"In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug\u2013drug interactions","volume":"232","author":"Lee","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.phrs.2016.05.013_bib0135","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1124\/dmd.111.039602","article-title":"Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities","volume":"39","author":"Mohamed","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phrs.2016.05.013_bib0140","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jep.2011.08.042","article-title":"In vitro and in situ evaluation of herb-drug interactions during intestinal metabolism and absorption of baicalein","volume":"141","author":"Fong","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0145","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2133\/dmpk.24.490","article-title":"Inhibitory effects of kampo medicine on human UGT2B7 activity","volume":"24","author":"Nakagawa","year":"2009","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.phrs.2016.05.013_bib0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.taap.2012.12.019","article-title":"Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferase (UGTS)","volume":"267","author":"Fang","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.fct.2014.06.020","article-title":"Evaluation of the in vitro\/in vivo potential of five berries (bilberry, blueberry, cranberry, elderberry, and raspberry ketones) commonly used as herbal supplements to inhibit uridine diphospho-glucuronosyltransferase","volume":"72","author":"Choi","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0160","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1124\/dmd.114.062141","article-title":"Targeted screen for human UDP-glucuronosyltransferase inhibitors and the evaluation of potential drug\u2013drug interactions with zafirlukast","volume":"43","author":"Oda","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phrs.2016.05.013_bib0165","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3109\/00498254.2012.681814","article-title":"Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9","volume":"42","author":"Zhu","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.phrs.2016.05.013_bib0170","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/dmd.32.4.413","article-title":"Human UDP-glucuronosyltransferase: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid","volume":"32","author":"Uchaipichat","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phrs.2016.05.013_bib0175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-0029-1185946","article-title":"Increased oral AUC of baicalin in streptozotocin-induced diabetic rats due to the increased activity of intestinal beta-glucuronidase","volume":"76","author":"Liu","year":"2010","journal-title":"Planta Med."},{"key":"10.1016\/j.phrs.2016.05.013_bib0180","first-page":"212","article-title":"Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucuronosyltransferase in human liver","volume":"66","author":"Huang","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.phrs.2016.05.013_bib0185","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.pra.0000415076.28497.8e","article-title":"Clinically important differences in the pharmacokinetics of the ten newer atypical antipsychotics: part 1","volume":"18","author":"Preskorn","year":"2012","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.phrs.2016.05.013_bib0190","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1124\/dmd.111.038729","article-title":"In vitro metabolism of rivoglitazone, a novel peroxisome proliferator-activated receptor gamma agonist, in rat, monkey, and human liver microsomes and freshly isolated hepatocytes","volume":"39","author":"Uchiyama","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phrs.2016.05.013_bib0195","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.taap.2014.05.010","article-title":"Mechanisms of acetaminophen-induced cell death in primary human hepatocytes","volume":"279","author":"Xie","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0200","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/jpet.110.175356","article-title":"Three-dimensional quantitative structure-activity relationship studies on UGT1A9-mediated 3-O-glucuronidation of natural flavonols using a pharmacophore-based comparative molecular field analysis model","volume":"336","author":"Wu","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.05.013_bib0205","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","article-title":"Beware of q2!","volume":"20","author":"Golbraikh","year":"2002","journal-title":"J. Mol. Graphics Model."},{"key":"10.1016\/j.phrs.2016.05.013_bib0210","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2125.2006.02588.x","article-title":"Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation","volume":"61","author":"Uchaipichat","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0215","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1124\/mol.107.037952","article-title":"Critical roles of residues 36 and 40 in the phenol and tertiary amine aglycone substrate selectivities of UDP-glucuronosyltransferase 1A3 and 1A4","volume":"72","author":"Kubota","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0220","unstructured":"Jingjing Gao. The pharmacokinetics of diosgenin from herbal extract in tumor patients. Chinese Master's Theses Full-text Database, (2011), S1:E079-177-1."},{"key":"10.1016\/j.phrs.2016.05.013_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2125.1998.00050.x","article-title":"Sorivudine and 5-fluorouracil; a clinically significant drug\u2013drug interaction due to inhibition of dihydropyrimidine dehydrogenase","volume":"46","author":"Diasio","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.05.013_bib0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-200038010-00003","article-title":"Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition","volume":"38","author":"Dresser","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.phrs.2016.05.013_bib0235","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/jpet.104.068536","volume":"311","author":"Shitara","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.05.013_bib0240","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1194\/jlr.M040519","article-title":"A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders","volume":"54","author":"Fang","year":"2013","journal-title":"J. Lipid Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181630250X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181630250X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T19:52:36Z","timestamp":1536695556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366181630250X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":48,"alternative-id":["S104366181630250X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.013","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}